Integrated Clinical Development
Integrated Clinical Development
Integrated Clinical Development
The Micron Group provides end-to-end clinical development services, supporting biotechs, pharma, and medical device companies from first-in-human trials through Phase I–III studies, post-marketing research, and real-world evidence (RWE) programs. Our expertise spans capacity development, clinical trial management, data management services, and regulatory support, ensuring every project is delivered with scientific rigor, operational excellence, and a clear path to approval.
Capacity Development
Capacity development in healthcare, as practiced by The Micron Group, is a strategic process focused on enhancing the capabilities of individuals and healthcare organisations to deliver improved health outcomes across clinical, operational, and research domains.
Clinical Trial Management
We offer both on-site and remote monitoring services tailored to the specific needs of your study, ensuring flexibility and cost-efficiency.
Data Management Services
The Micron Group is trusted for comprehensive clinical data management solutions that ensure data integrity, efficiency and regulatory compliance for all phases of clinical research and development.
First-in-Human
At The Micron Group, we support your product’s clinical development from First-in-Human (FIH) trials through to regulatory approval, offering specialised early-phase clinical trial services.
Medical Devices
Regulatory assessment of medical device development has become increasingly stringent, with differing frameworks and requirements across the UK, EU, and US markets. However, all jurisdictions demand high-quality clinical studies for medical device approval.
Phase I - III Clinical Studies
The Micron Group’s clinical operations team has extensive experience managing all phases of clinical trial services, including site identification and recruitment, clinical trial monitoring, and clinical data management. Let The Micron Group guide your clinical development programme from concept to regulatory approval — with efficiency, deep expertise, and a commitment to uncompromised quality.
Post-Marketing and RWE studies
Our expertise includes the conduct of real-world evidence (RWE) studies, whether for early-stage data gathering or to generate a foundation for larger observational or registration studies.
Regulatory Support
Our in-depth knowledge of global regulatory submission requirements allows us to guide clients through the complexities of clinical trial approvals and regulatory pathways.
